Breaking News

Theorem Expands Cardio Capabilities

By Kristin Brooks | January 7, 2014

Forms strategic alliance with BioTelemetry division

Theorem Clinical Research has entered a strategic alliance with BioTelemetry, Inc. and its clinical research division Cardiocore, a global cardiac core lab. Financial terms of the pact were not disclosed.
 
Discussing the alliance, John Potthoff, Theorem president and chief executive officer, remarked, “Theorem’s business strategy is to offer our clients the very best in every service area. BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry’s expert consulting services and deep experience across all major therapeutic areas.”
 
BioTelemetry’s chief executive officer, Joseph Capper, said, “Theorem’s experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s unique position that spans from clinical research through post-market surveillance and into clinical practice.  Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important